Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
Category: Generic Brands and Products
-
Drug Shortages Near an All-Time High, Leading to Rationing
A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.
-
Higher Food Prices Bring Bigger Profits, but Consumers Start to Resist
Some of the biggest packaged food companies raised their prices last quarter and their profits rose, but some customers were starting to cut back or trade down.
-
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market
The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The New York Times – Business:The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
The New York Times – Business:Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
-
F.D.A. Confirms Widespread Shortages of Adderall
The New York Times – Business:The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.